Skip to main content
Clinical Trials/NL-OMON51182
NL-OMON51182
Withdrawn
Not Applicable

Multi Country Study to Evaluate Patient Satisfaction for Non-Invasive Fat Reduction in Abdomen, Flanks, Upper Arms, Inner Thighs, Outer Thighs and Submental Area (NuCOOL) - MED-MA-PLS-0647

Allergan Aesthetics, an AbbVie Company0 sites11 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
on-Invasive Fat Reduction
Sponsor
Allergan Aesthetics, an AbbVie Company
Enrollment
11
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participant must be in good health as determined by medical history,
  • physical examination, vital signs, and investigator\*s judgment, including no
  • known active pandemic infection.
  • 2\. Participant (healthy volunteers) has read and signed the study written ICF.
  • 3\. Male or female participant 22 to 65 years of age inclusive at screening.
  • 4\. Participant has clearly visible and palpable fat in the abdomen and flanks,
  • and participant may also be assessed for visible and palpable fat in one or
  • more of the following body areas: left and right lower aspects of the upper
  • arms, left and right inner thigh, left and right outer thigh, or submental
  • area, which in the investigator\*s opinion is appropriate for and may benefit

Exclusion Criteria

  • 1\. Participant has a history of an invasive fat reduction procedure (eg,
  • liposuction, surgery, lipolytic agents, etc) within or adjacent to the area
  • being considered for treatment.
  • 2\. Participant has implants (eg, breast implants) in or immediately adjacent to
  • the area of intended treatment.
  • 3\. Participant has a history of prior surgery or scar tissue related to the
  • area being considered for treatment.
  • 4\. Participant has a known history of cryoglobulinemia, cold urticaria, cold
  • agglutinin disease, or paroxysmal cold hemoglobinuria.
  • 5\. Participant has a known sensitivity to cold or has any condition with a

Outcomes

Primary Outcomes

Not specified

Similar Trials